Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 84

1.

PIP30/FAM192A is a novel regulator of the nuclear proteasome activator PA28γ.

Jonik-Nowak B, Menneteau T, Fesquet D, Baldin V, Bonne-Andrea C, Méchali F, Fabre B, Boisguerin P, de Rossi S, Henriquet C, Pugnière M, Ducoux-Petit M, Burlet-Schiltz O, Lamond AI, Fort P, Boulon S, Bousquet MP, Coux O.

Proc Natl Acad Sci U S A. 2018 Jul 10;115(28):E6477-E6486. doi: 10.1073/pnas.1722299115. Epub 2018 Jun 22.

2.

Preventive fraction of physical fitness on risk factors in cardiac patients: Retrospective epidemiological study.

Caru M, Kern L, Bousquet M, Curnier D.

World J Cardiol. 2018 Apr 26;10(4):26-34. doi: 10.4330/wjc.v10.i4.26.

3.

HadD, a novel fatty acid synthase type II protein, is essential for alpha- and epoxy-mycolic acid biosynthesis and mycobacterial fitness.

Lefebvre C, Boulon R, Ducoux M, Gavalda S, Laval F, Jamet S, Eynard N, Lemassu A, Cam K, Bousquet MP, Bardou F, Burlet-Schiltz O, Daffé M, Quémard A.

Sci Rep. 2018 Apr 16;8(1):6034. doi: 10.1038/s41598-018-24380-5.

4.

Practitioners' Views on IPV and Its Solutions: An Integrative Literature Review.

Labarre M, Brodeur N, Roy V, Bousquet MA.

Trauma Violence Abuse. 2017 Jan 1:1524838017728709. doi: 10.1177/1524838017728709. [Epub ahead of print]

PMID:
29334022
5.

Long non-coding RNA expression profile in cytogenetically normal acute myeloid leukemia identifies a distinct signature and a new biomarker in NPM1-mutated patients.

De Clara E, Gourvest M, Ma H, Vergez F, Tosolini M, Dejean S, Demur C, Delabesse E, Recher C, Touriol C, Martelli MP, Falini B, Brousset P, Bousquet M.

Haematologica. 2017 Oct;102(10):1718-1726. doi: 10.3324/haematol.2017.171645. Epub 2017 Jul 4.

6.

Impaired thermoregulation and beneficial effects of thermoneutrality in the 3×Tg-AD model of Alzheimer's disease.

Vandal M, White PJ, Tournissac M, Tremblay C, St-Amour I, Drouin-Ouellet J, Bousquet M, Traversy MT, Planel E, Marette A, Calon F.

Neurobiol Aging. 2016 Jul;43:47-57. doi: 10.1016/j.neurobiolaging.2016.03.024. Epub 2016 Mar 30.

PMID:
27255814
7.

[Perceptual gap between oncologists/oncology nurses and patients in the management and impact of chemotherapy/radiotherapy-induced nausea and vomiting: French results of the GAP survey].

Morin S, Leurs I, Bousquet MN, Scotté F.

Bull Cancer. 2016 May;103(5):469-77. doi: 10.1016/j.bulcan.2016.02.011. Epub 2016 Mar 22. French.

PMID:
27015797
8.

Multidimensional Screening Platform for Simultaneously Targeting Oncogenic KRAS and Hypoxia-Inducible Factors Pathways in Colorectal Cancer.

Bousquet MS, Ma JJ, Ratnayake R, Havre PA, Yao J, Dang NH, Paul VJ, Carney TJ, Dang LH, Luesch H.

ACS Chem Biol. 2016 May 20;11(5):1322-31. doi: 10.1021/acschembio.5b00860. Epub 2016 Mar 3.

9.

Whole-exome sequencing in osteosarcoma reveals important heterogeneity of genetic alterations.

Bousquet M, Noirot C, Accadbled F, Sales de Gauzy J, Castex MP, Brousset P, Gomez-Brouchet A.

Ann Oncol. 2016 Apr;27(4):738-44. doi: 10.1093/annonc/mdw009. Epub 2016 Jan 19.

PMID:
26787232
10.

[Cardiac rehabilitation: physiologic basis, beneficial effects and contraindications].

Bounhoure JP, Bousquet M.

Bull Acad Natl Med. 2014 Mar;198(3):491-9. Review. French.

PMID:
26427292
11.

RNA editing in acute myeloid leukaemia with normal karyotype.

Quelen C, Eloit Y, Noirot C, Bousquet M, Brousset P.

Br J Haematol. 2016 Jun;173(5):788-90. doi: 10.1111/bjh.13631. Epub 2015 Aug 7. No abstract available.

PMID:
26251186
12.

Cystamine/cysteamine rescues the dopaminergic system and shows neurorestorative properties in an animal model of Parkinson's disease.

Cisbani G, Drouin-Ouellet J, Gibrat C, Saint-Pierre M, Lagacé M, Badrinarayanan S, Lavallée-Bourget MH, Charest J, Chabrat A, Boivin L, Lebel M, Bousquet M, Lévesque M, Cicchetti F.

Neurobiol Dis. 2015 Oct;82:430-444. doi: 10.1016/j.nbd.2015.07.012. Epub 2015 Jul 29.

PMID:
26232588
13.

Small nucleolar RNA expression profiles refine the prognostic impact of IGHV mutational status on treatment-free survival in chronic lymphocytic leukaemia.

Berquet L, Valleron W, Grgurevic S, Quelen C, Zaki O, Quillet-Mary A, Davi F, Brousset P, Bousquet M, Ysebaert L.

Br J Haematol. 2016 Mar;172(5):819-23. doi: 10.1111/bjh.13544. Epub 2015 Jun 11. No abstract available.

PMID:
26095450
14.

Discovery of ML358, a Selective Small Molecule Inhibitor of the SKN-1 Pathway Involved in Drug Detoxification and Resistance in Nematodes.

Peddibhotla S, Fontaine P, Leung CK, Maloney P, Hershberger PM, Wang Y, Bousquet MS, Luesch H, Mangravita-Novo A, Pinkerton AB, Smith LH, Malany S, Choe K.

ACS Chem Biol. 2015 Aug 21;10(8):1871-9. doi: 10.1021/acschembio.5b00304. Epub 2015 May 22.

PMID:
25946346
15.

Improved Walking Claudication Distance with Transcutaneous Electrical Nerve Stimulation: An Old Treatment with a New Indication in Patients with Peripheral Artery Disease.

Labrunée M, Boned A, Granger R, Bousquet M, Jordan C, Richard L, Garrigues D, Gremeaux V, Sénard JM, Pathak A, Guiraud T.

Am J Phys Med Rehabil. 2015 Nov;94(11):941-9. doi: 10.1097/PHM.0000000000000277.

PMID:
25802954
16.

Myeloid neoplasm with translocation t(2;11)(p21;q23-24), elevated microRNA 125b-1, and JAK2 exon 12 mutation.

McCormick SR, Higgins RR, Grutkoski PS, Bousquet M, Quelen C, Bartholomaus LM, Brousset P.

Br J Haematol. 2015 Apr;169(2):290-3. doi: 10.1111/bjh.13190. Epub 2014 Oct 15. No abstract available.

PMID:
25316507
17.

A high throughput screen for inhibitors of nematode detoxification genes.

Peddibhotla S, Leung CK, Maloney P, Hershberger PM, Nguyen K, Vasile S, Suyama E, Kane A, Bousquet MS, Leusch H, Stonich D, Mangravita-Novo A, Salaniwal S, Kung P, Diwan J, Smith LH, Chung TDY, Pinkerton AB, Malany S, Choe K.

Probe Reports from the NIH Molecular Libraries Program [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2010-.
2013 Apr 11 [updated 2014 Jan 13].

18.

Whole-body strength training using a Huber Motion Lab in coronary heart disease patients: safety, tolerance, fuel selection, and energy expenditure aspects and optimization.

Guiraud T, Labrunée M, Pillard F, Granger R, Bousquet M, Richard L, Boned A, Pathak A, Gayda M, Gremeaux V.

Am J Phys Med Rehabil. 2015 May;94(5):385-94. doi: 10.1097/PHM.0000000000000181.

PMID:
25171664
19.

Multifunctional redox polymers: electrochrome, polyelectrolyte, sensor, electrode modifier, nanoparticle stabilizer, and catalyst template.

Deraedt C, Rapakousiou A, Wang Y, Salmon L, Bousquet M, Astruc D.

Angew Chem Int Ed Engl. 2014 Aug 4;53(32):8445-9. doi: 10.1002/anie.201403062. Epub 2014 May 28.

PMID:
24889183
20.

miR-150 blocks MLL-AF9-associated leukemia through oncogene repression.

Bousquet M, Zhuang G, Meng C, Ying W, Cheruku PS, Shie AT, Wang S, Ge G, Wong P, Wang G, Safe S, Zhou B.

Mol Cancer Res. 2013 Aug;11(8):912-22. doi: 10.1158/1541-7786.MCR-13-0002-T. Epub 2013 Apr 19.

21.

High-intensity interval exercise improves vagal tone and decreases arrhythmias in chronic heart failure.

Guiraud T, Labrunee M, Gaucher-Cazalis K, Despas F, Meyer P, Bosquet L, Gales C, Vaccaro A, Bousquet M, Galinier M, Sénard JM, Pathak A.

Med Sci Sports Exerc. 2013 Oct;45(10):1861-7. doi: 10.1249/MSS.0b013e3182967559.

PMID:
23591293
22.

Impact of intravenous immunoglobulin on the dopaminergic system and immune response in the acute MPTP mouse model of Parkinson's disease.

St-Amour I, Bousquet M, Paré I, Drouin-Ouellet J, Cicchetti F, Bazin R, Calon F.

J Neuroinflammation. 2012 Oct 9;9:234. doi: 10.1186/1742-2094-9-234.

23.

Telephone support oriented by accelerometric measurements enhances adherence to physical activity recommendations in noncompliant patients after a cardiac rehabilitation program.

Guiraud T, Granger R, Gremeaux V, Bousquet M, Richard L, Soukarié L, Babin T, Labrunée M, Sanguignol F, Bosquet L, Golay A, Pathak A.

Arch Phys Med Rehabil. 2012 Dec;93(12):2141-7. doi: 10.1016/j.apmr.2012.06.027. Epub 2012 Jul 16.

PMID:
22813832
24.

Accelerometer as a tool to assess sedentarity and adherence to physical activity recommendations after cardiac rehabilitation program.

Guiraud T, Granger R, Gremeaux V, Bousquet M, Richard L, Soukarie L, Babin T, Labrunee M, Bosquet L, Pathak A.

Ann Phys Rehabil Med. 2012 Jul;55(5):312-21. doi: 10.1016/j.rehab.2012.05.002. Epub 2012 Jun 12. English, French.

25.

MicroRNA-125b transforms myeloid cell lines by repressing multiple mRNA.

Bousquet M, Nguyen D, Chen C, Shields L, Lodish HF.

Haematologica. 2012 Nov;97(11):1713-21. doi: 10.3324/haematol.2011.061515. Epub 2012 Jun 11.

26.

Validity of a questionnaire to assess the physical activity level in coronary artery disease patients.

Guiraud T, Granger R, Bousquet M, Gremeaux V.

Int J Rehabil Res. 2012 Sep;35(3):270-4. doi: 10.1097/MRR.0b013e3283531023.

PMID:
22584380
27.

B-cell regulator of immunoglobulin heavy-chain transcription (Bright)/ARID3a is a direct target of the oncomir microRNA-125b in progenitor B-cells.

Puissegur MP, Eichner R, Quelen C, Coyaud E, Mari B, Lebrigand K, Broccardo C, Nguyen-Khac F, Bousquet M, Brousset P.

Leukemia. 2012 Oct;26(10):2224-32. doi: 10.1038/leu.2012.95. Epub 2012 Apr 3.

PMID:
22469780
28.

Defective dentate nucleus GABA receptors in essential tremor.

Paris-Robidas S, Brochu E, Sintes M, Emond V, Bousquet M, Vandal M, Pilote M, Tremblay C, Di Paolo T, Rajput AH, Rajput A, Calon F.

Brain. 2012 Jan;135(Pt 1):105-16. doi: 10.1093/brain/awr301. Epub 2011 Nov 26.

PMID:
22120148
29.

The role of the MYD88-dependent pathway in MPTP-induced brain dopaminergic degeneration.

Drouin-Ouellet J, Gibrat C, Bousquet M, Calon F, Kriz J, Cicchetti F.

J Neuroinflammation. 2011 Oct 11;8:137. doi: 10.1186/1742-2094-8-137.

30.

High-fat diet exacerbates MPTP-induced dopaminergic degeneration in mice.

Bousquet M, St-Amour I, Vandal M, Julien P, Cicchetti F, Calon F.

Neurobiol Dis. 2012 Jan;45(1):529-38. doi: 10.1016/j.nbd.2011.09.009. Epub 2011 Sep 21.

PMID:
21971528
31.

MicroRNAs: the primary cause or a determinant of progression in leukemia?

Bousquet M, Lodish HF.

Expert Rev Hematol. 2011 Apr;4(2):121-3. doi: 10.1586/ehm.11.6. No abstract available.

32.

Impact of ω-3 fatty acids in Parkinson's disease.

Bousquet M, Calon F, Cicchetti F.

Ageing Res Rev. 2011 Sep;10(4):453-63. doi: 10.1016/j.arr.2011.03.001. Epub 2011 Mar 23. Review.

PMID:
21414422
33.

Short-term impact of a 4-week intensive cardiac rehabilitation program on quality of life and anxiety-depression.

Duarte Freitas P, Haida A, Bousquet M, Richard L, Mauriège P, Guiraud T.

Ann Phys Rehabil Med. 2011 May;54(3):132-43. doi: 10.1016/j.rehab.2011.02.001. Epub 2011 Mar 1. English, French.

34.

[Development of experienced pediatric nurses, accounts of experiences].

Vézole H, Bouschbacher C, Lemaître A, Plan O, Rigat M, Bousquet M, Pyz A, Odoyer-Roussel F, Bernard S, Perez A, Kerjouan V, Gosse S, Vallecillo I, Winter S.

Soins Pediatr Pueric. 2010 Nov-Dec;(257):30-6. French. No abstract available.

PMID:
21180195
35.

MicroRNA miR-125b causes leukemia.

Bousquet M, Harris MH, Zhou B, Lodish HF.

Proc Natl Acad Sci U S A. 2010 Dec 14;107(50):21558-63. doi: 10.1073/pnas.1016611107. Epub 2010 Nov 30.

36.

Transgenic conversion of omega-6 into omega-3 fatty acids in a mouse model of Parkinson's disease.

Bousquet M, Gue K, Emond V, Julien P, Kang JX, Cicchetti F, Calon F.

J Lipid Res. 2011 Feb;52(2):263-71. doi: 10.1194/jlr.M011692. Epub 2010 Nov 29.

37.

Cystamine metabolism and brain transport properties: clinical implications for neurodegenerative diseases.

Bousquet M, Gibrat C, Ouellet M, Rouillard C, Calon F, Cicchetti F.

J Neurochem. 2010 Sep;114(6):1651-8. doi: 10.1111/j.1471-4159.2010.06874.x. Epub 2010 Aug 19.

38.

Wide diversity of PAX5 alterations in B-ALL: a Groupe Francophone de Cytogenetique Hematologique study.

Coyaud E, Struski S, Prade N, Familiades J, Eichner R, Quelen C, Bousquet M, Mugneret F, Talmant P, Pages MP, Lefebvre C, Penther D, Lippert E, Nadal N, Taviaux S, Poppe B, Luquet I, Baranger L, Eclache V, Radford I, Barin C, Mozziconacci MJ, Lafage-Pochitaloff M, Antoine-Poirel H, Charrin C, Perot C, Terre C, Brousset P, Dastugue N, Broccardo C.

Blood. 2010 Apr 15;115(15):3089-97. doi: 10.1182/blood-2009-07-234229. Epub 2010 Feb 16.

39.

Cystamine prevents MPTP-induced toxicity in young adult mice via the up-regulation of the brain-derived neurotrophic factor.

Gibrat C, Bousquet M, Saint-Pierre M, Lévesque D, Calon F, Rouillard C, Cicchetti F.

Prog Neuropsychopharmacol Biol Psychiatry. 2010 Feb 1;34(1):193-203. doi: 10.1016/j.pnpbp.2009.11.005. Epub 2009 Nov 11.

PMID:
19913065
40.

Modulation of brain-derived neurotrophic factor as a potential neuroprotective mechanism of action of omega-3 fatty acids in a parkinsonian animal model.

Bousquet M, Gibrat C, Saint-Pierre M, Julien C, Calon F, Cicchetti F.

Prog Neuropsychopharmacol Biol Psychiatry. 2009 Nov 13;33(8):1401-8. doi: 10.1016/j.pnpbp.2009.07.018. Epub 2009 Jul 24.

PMID:
19632286
41.

PAX5 mutations occur frequently in adult B-cell progenitor acute lymphoblastic leukemia and PAX5 haploinsufficiency is associated with BCR-ABL1 and TCF3-PBX1 fusion genes: a GRAALL study.

Familiades J, Bousquet M, Lafage-Pochitaloff M, Béné MC, Beldjord K, De Vos J, Dastugue N, Coyaud E, Struski S, Quelen C, Prade-Houdellier N, Dobbelstein S, Cayuela JM, Soulier J, Grardel N, Preudhomme C, Cavé H, Blanchet O, Lhéritier V, Delannoy A, Chalandon Y, Ifrah N, Pigneux A, Brousset P, Macintyre EA, Huguet F, Dombret H, Broccardo C, Delabesse E.

Leukemia. 2009 Nov;23(11):1989-98. doi: 10.1038/leu.2009.135. Epub 2009 Jul 9.

PMID:
19587702
42.

Differences between subacute and chronic MPTP mice models: investigation of dopaminergic neuronal degeneration and alpha-synuclein inclusions.

Gibrat C, Saint-Pierre M, Bousquet M, Lévesque D, Rouillard C, Cicchetti F.

J Neurochem. 2009 Jun;109(5):1469-82. doi: 10.1111/j.1471-4159.2009.06072.x. Epub 2009 Mar 28.

43.

[MicroRNA and chromosomal translocations in hematologic malignancies].

Bousquet M, Dastugue N, Brousset P.

Med Sci (Paris). 2009 Mar;25(3):229-31. doi: 10.1051/medsci/2009253229. French. No abstract available.

44.

The level of AKT phosphorylation on threonine 308 but not on serine 473 is associated with high-risk cytogenetics and predicts poor overall survival in acute myeloid leukaemia.

Gallay N, Dos Santos C, Cuzin L, Bousquet M, Simmonet Gouy V, Chaussade C, Attal M, Payrastre B, Demur C, Récher C.

Leukemia. 2009 Jun;23(6):1029-38. doi: 10.1038/leu.2008.395. Epub 2009 Jan 22.

PMID:
19158829
45.

Myeloid cell differentiation arrest by miR-125b-1 in myelodysplastic syndrome and acute myeloid leukemia with the t(2;11)(p21;q23) translocation.

Bousquet M, Quelen C, Rosati R, Mansat-De Mas V, La Starza R, Bastard C, Lippert E, Talmant P, Lafage-Pochitaloff M, Leroux D, Gervais C, Viguié F, Lai JL, Terre C, Beverlo B, Sambani C, Hagemeijer A, Marynen P, Delsol G, Dastugue N, Mecucci C, Brousset P.

J Exp Med. 2008 Oct 27;205(11):2499-506. doi: 10.1084/jem.20080285. Epub 2008 Oct 20.

46.

Primary diffuse large B-cell lymphoma of bone displays preferential rearrangements of the c-MYC or BCL2 gene.

Lima FP, Bousquet M, Gomez-Brouchet A, de Paiva GR, Amstalden EM, Soares FA, Dastugue N, Vassallo J, Brousset P.

Am J Clin Pathol. 2008 May;129(5):723-6. doi: 10.1309/CMPGPYTMFRM6RVQR.

PMID:
18426731
47.

Effects of short-term exercise and exercise training on cognitive function among patients with cardiac disease.

Carles S Jr, Curnier D, Pathak A, Roncalli J, Bousquet M, Garcia JL, Galinier M, Senard JM.

J Cardiopulm Rehabil Prev. 2007 Nov-Dec;27(6):395-9. doi: 10.1097/01.HCR.0000300268.00140.e6.

PMID:
18197075
48.

Beneficial effects of dietary omega-3 polyunsaturated fatty acid on toxin-induced neuronal degeneration in an animal model of Parkinson's disease.

Bousquet M, Saint-Pierre M, Julien C, Salem N Jr, Cicchetti F, Calon F.

FASEB J. 2008 Apr;22(4):1213-25. Epub 2007 Nov 21.

PMID:
18032633
49.

Malignant transformation of leg ulcers: a retrospective study of 85 cases.

Combemale P, Bousquet M, Kanitakis J, Bernard P; Angiodermatology Group, French Society of Dermatology.

J Eur Acad Dermatol Venereol. 2007 Aug;21(7):935-41.

PMID:
17659003
50.

[Influence of depression on the prognosis of cardiovascular diseases].

Bounhoure JP, Galinier M, Curnier D, Bousquet M, Bes A.

Bull Acad Natl Med. 2006 Nov;190(8):1723-31; discussion 1731-2. Review. French.

PMID:
17650755

Supplemental Content

Loading ...
Support Center